[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)
NQ Score
50/100
N1 Content Completeness
3
AI Summary (NQ-processed)
GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase year-over-year. The revenue figures for the biotechnology company, which specializes in precision medicine, demonstrate stable growth in its genetic testing services business.
AI analysis data is not yet available.